ArticlePharmaceuticals (Basel, Switzerland)2025

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study.

Hiroya Kitsunai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.